The treatment of patients with neurotrophic keratitis, a rare disease of the eye that can lead to blindness, has evolved beyond treating symptoms to treatment that targets the root cause of the disease – nerve damage. Thus, early diagnosis is critical. The interprofessional faculty share their real-world experience as they discuss the etiology, diagnosis, staging, and treatment of patients with neurotrophic keratitis. In addition to an overview of symptomatic care and emerging treatments, the safety, efficacy, storage, and administration of cenegermin are explained in detail. Clinical and real-world questions are discussed, related to patient education, provided by the interprofessional, multidisciplinary team.

This activity is also available as a podcast: You may listen here

Presenting Faculty

• 

  Kenneth A. Beckman, MD, FACS

  Comprehensive EyeCare of Central Ohio, Westerville, Ohio
  The Ohio State University
  Columbus, Ohio

• 

  Stephanie L. Conway-Allen, PharmD, RPh

  Associate Professor of Pharmacy Practice
  Massachusetts College of Pharmacy and Health Sciences
  Worcester, Massachusetts

• 

  Preeya K. Gupta, MD

  Managing Director, Triangle Eye Consultants
  Raleigh, North Carolina
  Adjunct Associate Professor of Ophthalmology,
  Tulane University School of Medicine
  New Orleans, Louisiana